Tafenoquine (cas 106635-80-7) is not neurotoxic following supertherapeutic dosing in rats
-
Add time:08/01/2019 Source:sciencedirect.com
BackgroundTafenoquine (cas 106635-80-7) is a new drug for malaria prevention. The goal of the present work was to conduct a specific neurobehavioral study in rats with histopathological assessment of the brain.
We also recommend Trading Suppliers and Manufacturers of Tafenoquine (cas 106635-80-7). Pls Click Website Link as below: cas 106635-80-7 suppliers
Prev:Tafenoquine (cas 106635-80-7) for malaria prophylaxis in adults: An integrated safety analysis
Next:Interactions between Tafenoquine (cas 106635-80-7) and artemisinin-combination therapy partner drug in asexual and sexual stage Plasmodium falciparum) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Artesunate-Tafenoquine (cas 106635-80-7) combination therapy promotes clearance and abrogates transmission of the avian malaria parasite Plasmodium gallinaceum08/03/2019
- Interactions between Tafenoquine (cas 106635-80-7) and artemisinin-combination therapy partner drug in asexual and sexual stage Plasmodium falciparum08/02/2019
- Tafenoquine (cas 106635-80-7) for malaria prophylaxis in adults: An integrated safety analysis07/31/2019
